93 related articles for article (PubMed ID: 3290154)
1. Clinical use of ciprofloxacin: an interesting new oral antibiotic.
Berman SJ
Hawaii Med J; 1988 Apr; 47(4):162-4. PubMed ID: 3290154
[No Abstract] [Full Text] [Related]
2. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
[TBL] [Abstract][Full Text] [Related]
3. An assessment of ciprofloxacin per os in treatment of serious infections.
Dellamonica P; Bernard E; Etesse H; Garraffo R; Beziau H
Chemioterapia; 1987 Jun; 6(2 Suppl):391-4. PubMed ID: 3509456
[No Abstract] [Full Text] [Related]
4. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
Parish LC; Asper R
Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
[TBL] [Abstract][Full Text] [Related]
5. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin versus placebo in the treatment of acute bacterial diarrhea.
Pichler H; Diridl G; Stickler K; Wolf D
Chemioterapia; 1987 Jun; 6(2 Suppl):490-1. PubMed ID: 3334608
[No Abstract] [Full Text] [Related]
7. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.
Goldstein EJ; Kahn RM; Alpert ML; Ginsberg BP; Greenway FL; Citron DM
Am J Med; 1987 Apr; 82(4A):284-7. PubMed ID: 3555049
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin treatment of acute infections in immunocompromised host.
Nemes G; Heuser Y; Stolle D; Piroth HD; Nemes P
J Chemother; 1989 Jul; 1(4 Suppl):722-3. PubMed ID: 16312607
[No Abstract] [Full Text] [Related]
10. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
Lorian V; Pavletich K
Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
[TBL] [Abstract][Full Text] [Related]
11. Oral ciprofloxacin for treatment of severe infections.
Lobo IM; Silva NF; Assef MC; Mangini C; Silva ML; Bortoletto ML; Mendonça JS; Levi GC
Int J Clin Pharmacol Res; 1993; 13(2):81-5. PubMed ID: 8354593
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin versus cefotaxime in skin and skin structure infections: a double-blind study.
Ramirez-Ronda C; Saavedra S
Chemioterapia; 1987 Jun; 6(2 Suppl):432-4. PubMed ID: 3334591
[No Abstract] [Full Text] [Related]
13. Follow-up therapy with ciprofloxacin in severe infection, an alternative to parenteral treatment.
Bassaris HP; Chrysanthopoulos CJ; Skouelis AT; Starakis JC
J Chemother; 1989 Jul; 1(4 Suppl):676-7. PubMed ID: 16312588
[No Abstract] [Full Text] [Related]
14. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
15. Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics.
Nix DE; Cumbo TJ; Kuritzky P; DeVito JM; Schentag JJ
Am J Med; 1987 Apr; 82(4A):146-53. PubMed ID: 3555029
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
Esposito S; Galante D; Bianchi W; Gagliardi R
Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038
[TBL] [Abstract][Full Text] [Related]
17. A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Nicodemo AC; Robledo JA; Jasovich A; Neto W
Int J Clin Pract; 1998 Mar; 52(2):69-74. PubMed ID: 9624783
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.
Greenberg RN; Tice AD; Marsh PK; Craven PC; Reilly PM; Bollinger M; Weinandt WJ
Am J Med; 1987 Apr; 82(4A):266-9. PubMed ID: 3555046
[TBL] [Abstract][Full Text] [Related]
19. Oral ciprofloxacin in resistant urinary tract infections.
Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of oral ciprofloxacin in pelvic inflammatory disease.
De Wilde R
J Chemother; 1989 Jul; 1(4 Suppl):896-7. PubMed ID: 16312693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
